Ipsen S.A. acquisition of certain assets of Merrimack Pharmaceuticals, Inc. | Practical Law

Ipsen S.A. acquisition of certain assets of Merrimack Pharmaceuticals, Inc. | Practical Law

Ipsen S.A. acquisition of certain assets of Merrimack Pharmaceuticals, Inc.

Ipsen S.A. acquisition of certain assets of Merrimack Pharmaceuticals, Inc.

January 07, 2017Private Acquisition Agreements$575 million (subject to purchase price adjustment and additional earn-out payment).
End of Document

© 2024 Thomson Reuters. No claim to original U.S. Government Works.